Glycosylated hemoglobin level in the second trimester predicts birth weight and amniotic fluid volume in non-diabetic pregnancies with abnormal screening test
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To investigate relationship between glycemic control in first half of pregnancy by measuring mid-pregnancy HbA1c and neonatal birth weight and amniotic fluid volume. METHODS: We prospectively enrolled 220 pregnant women who received oral glucose tolerance test (OGTT) after positive gestational diabetes mellitus screening. We included 102 women with normal OGTT results into final analysis. We measured birth weight and amniotic fluid index (AFI) at 32-34 weeks. RESULTS: Mean birth weight was 3313±426 g, and 15.7% of neonates were classified as large-for-gestational age (LGA). Mean Hb1Ac was 4.96±0.28%. Median AFI was 145 mm, and polyhydramnios rate was 2.9%. Birth weight was positively correlated with HbA1c level (r=0.373, p<0.001) and pre-pregnancy body mass index (BMI; r=0.351, p<0.001). Linear regression analysis showed that HbA1c and pre-pregnancy BMI were positive independent determinants of neonatal birth weight, and HbA1c was positive independent determinant of AFI. Receiver operating characteristics curve identified HbA1c level of 4.99 as optimal threshold for prediction of LGA with 93.8% sensitivity, 61.6% specificity and positive likelihood ratio (+LR) of 2.45 and pre-pregnancy BMI value of 25.2 as optimal threshold for prediction of LGA with 81.3% sensitivity, 57% specificity and +LR of 1.9. CONCLUSION: In non-diabetic pregnant women with abnormal screening test, mid-pregnancy HbA1c level and pre-pregnancy BMI may predict neonatal birth weight. AFI in 32-34 weeks of gestation is related with mid-pregnancy HbA1c level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924
The influence of obesity and diabetes on the prevalence of macrosomia
Ehrenberg, H. M., Mercer, B. M., & Catalano, P. M. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.05.052 · Cited by 670 · cited 1×
“Obesity itself exerts significant influence on the risk of delivery of LGA infants independent of diabetes [26].”
BackgroundAssessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A 1c
Saudek, C. D., Derr, R. L., & Kalyani, R. R. (2006) · JAMA · doi:10.1001/jama.295.14.1688 · Cited by 373
HbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331 · cited 1×
“Lower HbA1c levels has been reported in pregnant women (in both diabetic and non-diabetic pregnancies) probably due to both lower fasting blood glucose and a shortened erythrocyte lifespan in pregnancy, prompting a proposal for lowering the upper normal limit for HbA1c in pregnancy [19].”
BackgroundIdiopathic polyhydramnios and perinatal outcome
Panting-Kemp, A., Nguyen, T., Chang, E., Quillen, E., & Castro, L. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70084-0 · Cited by 84 · cited 2×
“We measured AFI at 32–34 weeks of gestation because polyhydramnios is mostly diagnosed during this period [28].”
BackgroundMethod
Cited by
RETIRED: Diabetes in Pregnancy
Berger, H., Gagnon, R., & Sermer, M. (2016) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.04.002 · Cited by 108
Guideline No. 393-Diabetes in Pregnancy
Berger, H., Gagnon, R., & Sermer, M. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.03.008 · Cited by 106
WEI, Q., SUN, Z., YANG, Y., YU, H., DING, H., & WANG, S. (2016) · Scientific Reports · doi:10.1038/srep19920 · Cited by 99
Frequent monitoring of A1c during pregnancy as a treatment tool to guide therapy
Jovanovič, L., Savas, H., Mehta, M., Trujillo, A., & Pettitt, D. J. (2011) · Diabetes Care · doi:10.2337/dc10-1455 · Cited by 60
Metadata
- Authors
- Karcaaltincaba, D., Yalvac, S., Kandemir, O., & Altun, S.
- Venue
- The Journal of Maternal-Fetal & Neonatal Medicine
- Publisher
- Informa UK Limited
- Published
- 2010-01-11
- Volume
- 23
- Issue
- 10
- Pages
- 1193-1199
- ISSN
- 1476-4954 (ISSN-L)
- 1476-7058
- OpenAlex
- W2088668151
- Cited by
- 18
- References
- 5
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glycosylated hemoglobin level in the second trimester predicts birth weight and amniotic fluid volume in non-diabetic pregnancies with abnormal screening test. https://app.cochat.ai/papers/10.3109/14767050903511586
- The paper
- Karcaaltincaba, D., Yalvac, S., Kandemir, O., & Altun, S. (2010). Glycosylated hemoglobin level in the second trimester predicts birth weight and amniotic fluid volume in non-diabetic pregnancies with abnormal screening test. The Journal of Maternal-Fetal & Neonatal Medicine. https://doi.org/10.3109/14767050903511586
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.